Understanding Walgreens Boots Alliance Stock and Yield

If you're considering investing in Walgreens Boots Alliance, understanding the stock and yield is crucial. The company's stock is listed on the NASDAQ stock exchange under the ticker symbol WBA.

Walgreens Boots Alliance has a market capitalization of over $50 billion, making it one of the largest pharmacy chains in the world. Its stock has a beta of 0.83, indicating that it tends to move in sync with the overall market.

The company's dividend yield is around 4.5%, which is relatively high compared to other stocks in the industry. This suggests that investors may be attracted to the stock for its income potential.

Walgreens Boots Alliance's financial performance has been a mixed bag in recent years. For the fiscal year 2020, the company reported earnings of US$456 million, with an annual revenue of US$139.5 billion, an increase of 2.5% over the previous fiscal cycle.

The company's revenue has been steadily increasing, with a notable jump in 2015 to $103.44 billion. This growth continued in 2020, with revenue reaching $139.54 billion. However, the company has also experienced losses in certain years, such as in 2024, where losses were -$8.64 billion.

Here's a breakdown of the company's revenue growth over the years:

In 2024, the company's revenue was $147.66 billion, an increase of 6.17% compared to the previous year's $139.08 billion.

Walgreens Boots Alliance's revenue has seen a significant increase over the years, with a notable jump from $103.44 billion in 2015 to $139.08 billion in 2023.

In 2024, the company's revenue reached $147.66 billion, a 6.17% increase compared to the previous year. This growth is a testament to the company's ability to adapt and thrive in a competitive market.

The company's revenue has consistently been over $100 billion since 2015, with a peak of $139.08 billion in 2023. This level of revenue is a significant milestone for any business.

Walgreens Boots Alliance's net income has also experienced fluctuations over the years, with a notable loss of -$8.64 billion in 2024. This loss is a significant increase from the -$3.08 billion loss in 2023.

Here is a summary of the company's revenue and net income from 2023 to 2024:

The company's total assets have also seen fluctuations, with a notable increase from $96,628 million in 2023 to $81,037 million in 2024. This decrease in total assets is likely due to the company's significant losses in 2024.

Walgreens' high dividend yield is a notable aspect of its financial performance.

The company was on the cusp of becoming a Dividend King before drastically cutting its dividend yield.

This drastic cut is a key reason for the high yield, making it an attractive option for income investors.

Walgreens' financial situation has been a topic of interest, with its dividend yield serving as a clear indicator of its financial health.

The company's decision to cut its dividend yield has left some investors wondering about its long-term prospects.

Walgreens Boots Alliance's stock has had a wild ride in recent years. In 2025, investors experienced a 25% surge after the company's strong Q1 2025 earnings and revenue beat expectations.

Walgreens Boots Alliance's revenue was $147.66 billion in 2024, a 6.17% increase from the previous year. However, the company also reported losses of -$8.64 billion, a significant increase from 2023.

The stock took a hit in 2025, dropping 15% after a brief surge. This decline was likely due to the company's decision to suspend quarterly dividends to shore up its finances.

Investors are taking notice of the company's struggles, with law firms such as Bronstein, Gewirtz & Grossman, LLC and Rosen Law Firm announcing investigations into potential claims on behalf of Walgreens Boots Alliance shareholders.

Additional reading: 2021–2023 Inflation Surge

News about Walgreens Boots Alliance has been making headlines.

Rosen Law Firm, a global investor rights law firm, is investigating potential claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).

Bronstein, Gewirtz & Grossman, LLC is also investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company").

The investigations are related to the performance of Walgreens Boots Alliance, Inc. shares.

Broaden your view: Upside Potential Ratio